Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.

Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedVersion 3.3.3 updates the record to include full core content sections (Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Description, Study Status, Study Identification); a related IMvigor011 study reference was removed in a prior revision.SummaryDifference0.7%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag changed from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedFooter revision labels show software version updates (v3.3.1 and v3.2.0) without changing study history data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the generic government funding/operating status notice from the page header. No trial data, statuses, or contact information were changed.SummaryDifference0.4%

- Check65 days agoChange DetectedNew version entry appears in the history list, showing the latest submission date; core trial content and status remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check94 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference9%

Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.